Metformin limits osteoarthritis development and progression through activation of AMPK signalling
出版年份 2020 全文链接
标题
Metformin limits osteoarthritis development and progression through activation of AMPK signalling
作者
关键词
-
出版物
ANNALS OF THE RHEUMATIC DISEASES
Volume 79, Issue 5, Pages 635-645
出版商
BMJ
发表日期
2020-03-11
DOI
10.1136/annrheumdis-2019-216713
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metformin‐induced autophagy and irisin improves INS‐1 cell function and survival in high‐glucose environment via AMPK/SIRT1/PGC‐1α signal pathway
- (2019) Qingxue Li et al. Food Science & Nutrition
- Metformin inhibits the proliferation of rheumatoid arthritis fibroblast-like synoviocytes through IGF-IR/PI3K/AKT/m-TOR pathway
- (2019) Kun Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- Repurposing Metformin for Cardiovascular Disease
- (2018) Graham Rena et al. CIRCULATION
- The Therapeutic Potential of Metformin in Neurodegenerative Diseases
- (2018) Carola Rotermund et al. Frontiers in Endocrinology
- Metformin relieves neuropathic pain after spinal nerve ligation via autophagy flux stimulation
- (2018) Weidong Weng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Does metformin protect against osteoarthritis? An electronic health record cohort study
- (2017) Lauren A. Barnett et al. Primary Health Care Research and Development
- The AMPK Activator A769662 Blocks Voltage-Gated Sodium Channels: Discovery of a Novel Pharmacophore with Potential Utility for Analgesic Development
- (2017) Marina N. Asiedu et al. PLoS One
- Chondrocyte-Specific Ablation ofAMPKα1Does Not Affect Bone Development or Pathogenesis of Osteoarthritis in Mice
- (2016) Cheng Yang et al. DNA AND CELL BIOLOGY
- Emerging role of metabolic signaling in synovial joint remodeling and osteoarthritis
- (2016) Ronald K. June et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- The role of atp-activated protein kinase(AMPK) in the chondrocyte energy balance and IL-1β-induced production of MMP-13 in osteoarthritis(OA)
- (2016) N. Yui et al. OSTEOARTHRITIS AND CARTILAGE
- Metformin protects against apoptosis and senescence in nucleus pulposus cells and ameliorates disc degeneration in vivo
- (2016) Deheng Chen et al. Cell Death & Disease
- Metformin: A Hopeful Promise in Aging Research
- (2016) Marta G. Novelle et al. Cold Spring Harbor Perspectives in Medicine
- AMP-activated protein kinase (AMPK) activity negatively regulates chondrogenic differentiation
- (2015) Kenjiro Bandow et al. BONE
- AMPK Activation by A-769662 Controls IL-6 Expression in Inflammatory Arthritis
- (2015) Monica Guma et al. PLoS One
- Metformin Activates AMP-activated Protein Kinase by Promoting Formation of the αβγ Heterotrimeric Complex
- (2014) Shumei Meng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Emerging regulators of the inflammatory process in osteoarthritis
- (2014) Ru Liu-Bryan et al. Nature Reviews Rheumatology
- Metformin Beyond Diabetes: Pleiotropic Benefits of Metformin in Attenuation of Atherosclerosis
- (2014) Farshad Forouzandeh et al. Journal of the American Heart Association
- Linked decreases in liver kinase B1 and AMP-activated protein kinase activity modulate matrix catabolic responses to biomechanical injury in chondrocytes
- (2013) Freyr Petursson et al. ARTHRITIS RESEARCH & THERAPY
- Resveratrol Engages AMPK to Attenuate ERK and mTOR Signaling in Sensory Neurons and Inhibits Incision-Induced Acute and Chronic Pain
- (2012) Dipti V Tillu et al. Molecular Pain
- Chondrocyte AMP-activated protein kinase activity suppresses matrix degradation responses to proinflammatory cytokines interleukin-1β and tumor necrosis factor α
- (2011) Robert Terkeltaub et al. ARTHRITIS AND RHEUMATISM
- Epidemiology of Osteoarthritis
- (2010) Yuqing Zhang et al. CLINICS IN GERIATRIC MEDICINE
- Lifetime risk of symptomatic knee osteoarthritis
- (2008) Louise Murphy et al. ARTHRITIS AND RHEUMATISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More